Evaluating the Risks of Clinical Research

被引:70
|
作者
Rid, Annette [1 ,2 ]
Emanuel, Ezekiel J. [1 ]
Wendler, David [1 ]
机构
[1] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA
[2] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland
来源
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
PERCUTANEOUS LIVER-BIOPSY; HEALTH UTILITIES INDEX; QUALITY-OF-LIFE; PEDIATRIC RESEARCH; OPTIMAL NUMBER; MINIMAL RISK; IMMUNOTHERAPY; COMPLICATIONS; BENEFIT; ETHICS;
D O I
10.1001/jama.2010.1414
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ethical appropriateness of clinical research depends on protecting participants from excessive risks. Yet no systematic framework has been developed to assess research risks, and as a result, investigators, funders, and review boards rely only on their intuitive judgments. Because intuitive judgments of risk are subject to well-documented cognitive biases, this approach raises concern that research participants are not being adequately protected. To address this situation, we delineate a method called the systematic evaluation of research risks (SERR), which evaluates the risks of research interventions by comparing these interventions with the risks of comparator activities that have been deemed acceptable. This method involves a 4-step process: (1) identify the potential harms posed by the proposed research intervention; (2) categorize the magnitude of the potential harms into 1 of 7 harm levels on a harm scale; (3) quantify or estimate the likelihood of each potential harm; and (4) compare the likelihood of each potential harm from the research intervention with the likelihood of harms of the same magnitude occurring as a result of an appropriate comparator activity. By explicitly delineating, quantifying, and comparing the risks of research interventions with the risks posed by appropriate comparator activities, SERR offers a way to minimize the influence of cognitive biases on the evaluation of research risks and thereby better protect research participants from excessive risks. JAMA. 2010; 304(13): 1472-1479
引用
收藏
页码:1472 / 1479
页数:8
相关论文
共 50 条
  • [21] Understanding and evaluating research in applied and clinical settings
    Ryan, ND
    AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (04): : 754 - 754
  • [22] Evaluating a clinical research training program (CRTP).
    Perry, CA
    Moreland, LW
    Brown, S
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S403 - S403
  • [23] In Reply: Evaluating the Landscape of Clinical Research in Neurosurgery
    Karsy, Michael
    Wilde, Herschel
    Rolston, John D.
    NEUROSURGERY, 2019, 85 (04) : E795 - E795
  • [24] Managing the risks and benefits of clinical research in response to a pandemic
    Flume, Patrick A.
    Berbari, Elie F.
    Viera, Laura
    Hess, Rachel
    Higgins, Janine
    Armstrong, Jennifer
    Rice, Linda
    True, Laura
    Shaker, Reza
    Buse, John B.
    Panettieri, Reynold A., Jr.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 5 (01)
  • [25] Clinical Research Risks, Climate Change, and Human Health
    D'Souza, Jeff
    Samuel, Gabrielle
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (23): : 2247 - 2248
  • [27] Evaluating intergenerational risks
    Asheim, Geir B.
    Zuber, Stephane
    JOURNAL OF MATHEMATICAL ECONOMICS, 2016, 65 : 104 - 117
  • [28] Dioxins: evaluating the risks
    Ansay, MAJ
    ANNALES DE MEDECINE VETERINAIRE, 1999, 143 (06) : 365 - +
  • [29] EVALUATING THE RISKS IN ACQUISITION
    HERTZ, DB
    THOMAS, H
    LONG RANGE PLANNING, 1982, 15 (06) : 38 - 44
  • [30] Understanding and evaluating research in applied and clinical settings.
    Henrich, Christopher C.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (01): : 104 - 105